Colchicine in Patients with Chronic Coronary Disease

Cited by (1,001)

Items 101–200 of 1,001

1. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care
   Hyon K. Choi, Natalie McCormick, Chio Yokose · 2021 · Nature Reviews Rheumatology
2. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
   Anja Karlstaedt, Javid J. Moslehi, Rudolf A. de Boer · 2022 · Nature Reviews Cardiology
3. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome
   Gorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, Claes Held, Harvey Douglas White, Ralph Stewart, Wolfgang Köenig, Christopher Paul Cannon, Andrzej Budaj, Emil Hagström et al. · 2021 · JAMA Cardiology
4. Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review
   Michał Konwerski, Aleksandra Gąsecka, Grzegorz Opolski, Marcin Grabowski, Tomasz Mazurek · 2022 · Biology
5. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness
   Artemio García‐Escobar, Silvio Vera, Daniel Tébar Márquez, Borja Rivero Santana, Alfonso Jurado-Román y, Santiago Jiménez‐Valero, Guillermo Galeote, José Ángel Cabrera, Raúl Moreno · 2023 · Microvascular Research
6. Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial
   Miao Yu, Yong Yang, Silai Dong, Chen Zhao, Fen Yang, Yuan-Fan Yuan, Yu-Hua Liao, Shao-Lin He, Kun Liu, Fen Wei et al. · 2024 · Circulation
7. Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation
   Yuan Yao, Fan Li, Mao Zhang, Li Jin, Peng Xie, Dairu Liu, Junxia Zhang, Xinli Hu, Fengxiang Lv, Haibao Shang et al. · 2022 · Circulation Research
8. Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy
   Ridker, Paul M, Tuttle, Katherine R, Perkovic, Vlado, Libby, Peter, MacFadyen, Jean G · 2022 · European Heart Journal
9. IL-6 and Cardiovascular Risk: A Narrative Review
   Nehal N. Mehta, Emil M. deGoma, Michael David Shapiro · 2024 · Current Atherosclerosis Reports
10. Inflammatory Mediators of Endothelial Dysfunction
    Eirini Dri, Evangelos Lampas, George A. Lazaros, Emilia Lazarou, Panagiotis Theofilis, Costas P. Tsioufis, Dimitris Tousoulis · 2023 · Life
11. Statins and Inflammation
    Martin Satny, Jaroslav Alois Hubacek, Michal Vrablík · 2021 · Current Atherosclerosis Reports
12. The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications
    Xiaoyan Wang, Liming Chen, Jianming Wei, Hao Zheng, Ning Zhou, Xinjie Xu, Xin Deng, Tao Liu, Yunzeng Zou · 2025 · Signal Transduction and Targeted Therapy
13. Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Michelle Samuel, Jean‐Claude Tardif, Nadia Bouabdallaoui, Paul Khairy, Marie‐Pierre Dubé, Lucie Blondeau, Marie‐Claude Guertin · 2020 · Canadian Journal of Cardiology
14. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis
    Fabienne Burger, Daniela Baptista, Aline Roth, Rafaela da Silva, Fabrizio Montecucco, François Mach, Karim J. Brandt, Kapka Miteva · 2021 · International Journal of Molecular Sciences
15. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis
    Jan Hettwer, Julia Hinterdobler, Benedikt Miritsch, Marcus-André Deutsch, Xinghai Li, Carina Mauersberger, Aldo Moggio, Quinte Braster, Hermann Gram, Avril A. B. Robertson et al. · 2021 · Cardiovascular Research
16. Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors
    Gemma A. Figtree, Stephen Thomas Vernon, Jason A. Harmer, Michael Patrick Gray, Clare Gabrielle Arnott, Eric Bachour, Giannie Barsha, David B. Brieger, Alex D. H. Brown, David Stephen Celermajer et al. · 2023 · Journal of the American College of Cardiology
17. Hydrogel-load exosomes derived from dendritic cells improve cardiac function via Treg cells and the polarization of macrophages following myocardial infarction
    Youming Zhang, Zichun Cai, Yunli Shen, Qizheng Lu, Wei Gao, Xin Zhong, Yao Kang, Jie Yuan, Haibo Liu · 2021 · Journal of Nanobiotechnology
18. NLRP3 inflammasome: The rising star in cardiovascular diseases
    Yidan Zheng, Xu Li, Nianguo Dong, Fei Li · 2022 · Frontiers in Cardiovascular Medicine
19. Acute coronary syndromes: mechanisms, challenges, and new opportunities
    Simon C Kraler, Christian Eugen Mueller, Peter Libby, Deepak L. Bhatt · 2025 · European Heart Journal
20. Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies
    Thorsten Kessler, Heribert Schunkert · 2021 · JACC Basic to Translational Science
21. GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage
    Brady Park, Ehab Bakbak, Hwee Teoh, Aishwarya Krishnaraj, Fallon Dennis, Adrian Quan, Ori David Rotstein, Javed Butler, David A. Hess, Subodh Verma · 2024 · American Journal of Physiology-Heart and Circulatory Physiology
22. Inflammation in atherosclerosis: Lessons and therapeutic implications
    Peter Libby, Oliver Soehnlein · 2025 · Immunity
23. Inflammasomes and Atherosclerosis: a Mixed Picture
    Alan R. Tall, Karin Bornfeldt · 2023 · Circulation Research
24. Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication
    Alexios S. Antonopoulos, Andreas Angelopoulos, Paraskevi Papanikolaou, Spyridon Simantiris, Evangelos K. Oikonomou, Konstantinos Vamvakaris, Alkmini Koumpoura, Maria Farmaki, Marialena Trivella, Charalambos V. Vlachopoulos et al. · 2021 · JACC. Cardiovascular imaging
25. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review
    Alexia Rouland, David Masson, Laurent Lagrost, Bruno L Vergès, Thomas Gautier, Benjamin Bouillet · 2022 · Cardiovascular Diabetology
26. NETs-Induced Thrombosis Impacts on Cardiovascular and Chronic Kidney Disease
    Manovriti Thakur, Carolina Victória Cruz Junho, Sarah Bernhard, Marc Schindewolf, Heidi Noels, Yvonne Döring · 2023 · Circulation Research
27. Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
    Nick S. Nurmohamed, Alexander R. van Rosendael, Ibrahim Danad, Quyen Ngo‐Metzger, Pam R. Taub, Kausik Kumar Ray, Gemma A. Figtree, Marc P. Bonaca, Judith A. Hsia, Fátima Rodríguez et al. · 2024 · European Heart Journal
28. Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management
    James R. O’Dell, Mary T. Brophy, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, Hongsheng Wu, Anne Davis‐Karim, Jeff A. Newcomb, Ryan E Ferguson, David Pittman et al. · 2022 · NEJM Evidence
29. Regulated Necrosis in Atherosclerosis
    Pauline Puylaert, Michelle Zurek, Katey J. Rayner, Guido R.Y. De Meyer, Wim Martinet · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
30. Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives
    Frederik Flindt Kreiner, Jordan M Kraaijenhof, Matthias von Herrath, G. Kees Hovingh, Bernt Johan von Scholten · 2022 · Expert Review of Clinical Immunology
31. Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits
    Wong, Chi Kin, Drucker, Daniel J. · 2025 · Journal of Clinical Investigation
32. Circulating Interleukin-6 Levels and Incident Ischemic Stroke
    Ανδρέας Παπαδόπουλος, Konstantinos Palaiopanos, Harry Björkbacka, Annette Peters, James A. de Lemos, Sudha S. Seshadri, Martin Dichgans, Marios K. Georgakis · 2021 · Neurology
33. Clonal hematopoiesis in cardiovascular disease and therapeutic implications
    Alan R. Tall, José J. Fuster · 2022 · Nature Cardiovascular Research
34. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells
    Marie A.C. Depuydt, Frank H. Schaftenaar, Koen H.M. Prange, Arjan Boltjes, Esmeralda Hemme, Lucie Delfos, Jill de Mol, Maaike J.M. de Jong, Mireia N. A. Bernabé Kleijn, Judith A. H. M. Peeters et al. · 2023 · Nature Cardiovascular Research
35. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
    Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu, Pasquale Paolisso, Nunzia D’Onofrio, Lucia Scisciola, Rosalba La Grotta, Chiara Frigé, Franca Ferraraccio, Iacopo Panarese et al. · 2023 · Atherosclerosis
36. Macrophage profiling in atherosclerosis: understanding the unstable plaque
    Ioanna Gianopoulos, Stella Styliani Daskalopoulou · 2024 · Basic Research in Cardiology
37. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective
    Eleanor C. Murray, Ryszard Nosalski, Neil A. MacRitchie, Maciej Tomaszewski, Pasquale Maffia, David Glenn Harrison, Tomasz Jan Guzik · 2021 · Cardiovascular Research
38. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
    Robert A. Terkeltaub · 2023 · Drugs
39. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis
    Mustafa Yalçınkaya, Wenli Liu, Leigh-anne Thomas, Malgorzata Olszewska, Tong Xiao, Sandra Abramowicz, Eirini P. Papapetrou, Marit Westerterp, Nan Wang, Ira A. Tabas et al. · 2023 · Circulation
40. IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
    Glenn Matthew Chertow, Anna Marie Chang, Gary Michael Felker, Mark A. Heise, Elena Velkoska, Bengt Fellström, David M. Charytan, Regina A. Clementi, Charles Michael Gibson, Shaun G. Goodman et al. · 2024 · Nature Medicine
41. Colchicine’s Role in Cardiovascular Disease Management
    Leo Francis Buckley, Peter Libby · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
42. Osteopontin in Cardiovascular Diseases
    Kohsuke Shirakawa, Motoaki Sano · 2021 · Biomolecules
43. Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
    Gissette Reyes‐Soffer, Marit Westerterp · 2021 · Pharmacological Research
44. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
    Michael Lacy, Christina Bürger, Annelie Shami, Maiwand Ahmadsei, Holger Winkels, Katrin Nitz, Claudia M. van Tiel, Tom T. P. Seijkens, Pascal J. H. Kusters, Ela Karshovka et al. · 2021 · Nature Communications
45. Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
    Valeria Pellegrini, Rosalba La Grotta, Francesca Carreras, Angelica Giuliani, Jacopo Sabbatinelli, Fabiola Olivieri, Cesare Berra, Antonio Ceriello, Francesco Prattichizzo · 2024 · Cells
46. Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture–prone atherosclerotic plaques
    Andreas Edsfeldt, Maarten Swart, Pratibha Singh, Lea H. Dib, Jiangming Sun, Jennifer E. Cole, Inhye Park, Dania Al-Sharify, Ana Flor Persson, Mihaela Nitulescu et al. · 2022 · European Heart Journal
47. Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis
    Michelle Samuel, Colin Berry, Marie‐Pierre Dubé, Wolfgang Köenig, Jose Luis Lopez-Sendon, Aldo Pietro Maggioni, Fausto José Pinto, François Roubille, Jean‐Claude Tardif · 2025 · European Heart Journal
48. Atherosclerotic plaque stabilization and regression: a review of clinical evidence
    Ashish Sarraju, Steven E. Nissen · 2024 · Nature Reviews Cardiology
49. Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
    Amy Erica Lin, Aneesh C. Bapat, Ling Xiao, Abhishek Niroula, Jiangchuan Ye, Waihay J. Wong, Mridul Agrawal, Christopher J. Farady, Andreas Boettcher, Christopher A. Hergott et al. · 2024 · Circulation
50. Cardiovascular Disease in Myeloproliferative Neoplasms
    Orly Leiva, Gabriela Soriano Hobbs, Katya Ravid, Peter Libby · 2022 · JACC CardioOncology
51. Colchicine prevents accelerated atherosclerosis in TET2 -mutant clonal haematopoiesis
    María A. Zuriaga, Zhi Yu, Nuria Matesanz, Buu Minh Thanh Truong, Beatriz L. Ramos-Neble, M. Lopez, Md Mesbah Uddin, Tetsushi Nakao, Abhishek Niroula, Virginia Zorita et al. · 2024 · European Heart Journal
52. Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
    Faizan Mazhar, Anne‐Laure Faucon, Edouard L. Fu, Karolina Elisabeth Szummer, Jimmi Mathisen, Sofia Gerward, Simon Bertram Reuter, Nikolaus Marx, Roxana Mehran, Juan Jesús Carrero · 2024 · European Heart Journal
53. Inflammation and Cardiovascular Disease: The Future
    Natalie Arnold, Katharina Lechner, Christoph Waldeyer, Michael David Shapiro, Wolfgang Köenig · 2021 · European Cardiology Review
54. Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis
    Wenli Liu, Mustafa Yalçınkaya, Inés Fernández-Maestre, Malgorzata Olszewska, Patrick B. Ampomah, Jonathan Brett Heimlich, Ranran Wang, Pablo Sánchez Vela, Tong Xiao, Alexander G. Bick et al. · 2023 · Nature Cardiovascular Research
55. Assessing Cardiovascular Risk by Using the Fat Attenuation Index in Coronary CT Angiography
    Laura Valentina Klüner, Evangelos K. Oikonomou, Charalambos A. Antoniades · 2021 · Radiology Cardiothoracic Imaging
56. T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
    Kohsuke Shirakawa, Motoaki Sano · 2021 · Cells
57. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial
    David Conen, Michael Ke Wang, Ekaterine Popova, Matthew T.V. Chan, Giovanni Landoni, Juan P Cata, Cara Reimer, Sean R McLean, Sadeesh K Srinathan, Juan Carlos Trujillo-Reyes et al. · 2023 · The Lancet
58. The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches
    Panagiotis Tsioufis, Panagiotis Theofilis, Konstantinos P Tsioufis, Dimitris Tousoulis · 2022 · International Journal of Molecular Sciences
59. Targeting inflammation to reduce recurrent stroke
    Annaelle Zietz, Sarah Gorey, Peter J. Kelly, Katan Mira, John Joseph McCabe · 2023 · International Journal of Stroke
60. Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement
    Stefano Romeo, Antonio Vidal‐Puig, Mansoor Husain, Rexford S. Ahima, Marcello Arca, Deepak L. Bhatt, Anna Mae Diehl, Luigi Fontana, Roger Foo, Gema Frühbeck et al. · 2025 · European Heart Journal
61. Gout
    Ted R. Mikuls · 2022 · New England Journal of Medicine
62. Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches
    Abdul Waheed Khan, Karin Agnes Maria Jandeleit-Dahm · 2025 · Nature Reviews Cardiology
63. Trained immunity: induction of an inflammatory memory in disease
    Titus Schlüter, Yuri van Elsas, Bram Priem, Athanasios Ziogas, Mihai Gheorghe Netea · 2025 · Cell Research
64. Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease
    Akira Matsumori · 2023 · European Cardiology Review
65. High lipoprotein(a): Actionable strategies for risk assessment and mitigation
    Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, Wess Boatwright, Christie Mitchell Ballantyne · 2024 · American Journal of Preventive Cardiology
66. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
    Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José Manuel Boavida, Davide Capodanno et al. · 2022 · Revista Española de Cardiología
67. Low-dose colchicine for atherosclerosis: long-term safety
    Stefan Mark Nidorf, Eldad Ben‐Chetrit, Paul M. Ridker · 2024 · European Heart Journal
68. Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases
    Nicola Potere, Aldo Bonaventura, Antonio Abbate · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
69. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
    Scheller, Marina, Ludwig, Anne Kathrin, Göllner, Stefanie, Rohde, Christian, Krämer, Stephen, Stäble, Sina, Janssen, Maike, Müller, James-Arne, He, Lixiazi, Bäumer, Nicole et al. · 2021 · Nature Cancer
70. Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran Program
    Small, Aeron M., Peloso, Gina M., Linefsky, Jason, Aragam, Jayashri, Galloway, Ashley, Tanukonda, Vidisha, Wang, Lu-Chen, Yu, Zhi, Sunitha Selvaraj, Margaret, Farber-Eger, Eric H. et al. · 2023 · Circulation
71. CD47‐ and Integrin α4/β1‐Comodified‐Macrophage‐Membrane‐Coated Nanoparticles Enable Delivery of Colchicine to Atherosclerotic Plaque
    Yuyu Li, Junyi Che, Lei Chang, Meng Guo, Xue Bao, Dan Mu, Xuan Sun, Xin Zhang, Wen Lu, Jun Xie · 2021 · Advanced Healthcare Materials
72. Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
    Martina B. Lorey, Katariina Öörni, Petri T. Kovanen · 2022 · Frontiers in Cardiovascular Medicine
73. Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease
    Nalin H. Dayawansa, Sara Baratchi, Karlheinz Peter · 2022 · Frontiers in Cardiovascular Medicine
74. Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
    Tristram A.J. Ryan, Alexander Hooftman, Aisling M. Rehill, Matt D. Johansen, Eóin C. O’ Brien, Juliana Escher Toller-Kawahisa, Mieszko M. Wilk, Emily Anne Day, Hauke J. Weiss, Pourya Sarvari et al. · 2023 · Nature Communications
75. Immune and Inflammatory Networks in Myocardial Infarction: Current Research and Its Potential Implications for the Clinic
    Atsushi Anzai, Seien Ko, Keiichi Fukuda · 2022 · International Journal of Molecular Sciences
76. Immune System and Microvascular Remodeling in Humans
    Damiano Rizzoni, Carolina De Ciuceis, Piotr Szczepaniak, Pierre Paradis, Ernesto L. Schiffrin, Tomasz J. Guzik · 2022 · Hypertension
77. Targeting inflammation in atherosclerosis: overview, strategy and directions
    Ron Waksman, Ilan Merdler, Brian C. Case, Ori Waksman, Italo Porto · 2023 · EuroIntervention
78. Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells
    Wouter A. van der Heijden, Lisa Van de Wijer, Farid Keramati, Wim Trypsteen, Sofie Rutsaert, Rob ter Horst, Martin Jaeger, Hans J. P. M. Koenen, Hendrik G. Stunnenberg, Irma Joosten et al. · 2021 · JCI Insight
79. Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies
    Niek J. Pluijmert, Douwe E. Atsma, Paul H.A. Quax · 2021 · Frontiers in Cardiovascular Medicine
80. Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
    Anne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb · 2021 · European Cardiology Review
81. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality
    Takahito Doi, Anne Langsted, Børge Grønne Nordestgaard · 2023 · Atherosclerosis
82. Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation
    Nisha Schwarz, Sanuja Fernando, Yung‐Chih Chen, Thalia Salagaras, Sushma R. Rao, S. Liyanage, Anna E. Williamson, Deborah Toledo‐Flores, Catherine G. Dimasi, Timothy J. Sargeant et al. · 2023 · The FASEB Journal
83. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study
    Jiejie Li, Jinxi Lin, Yuesong Pan, Mengxing Wang, Xia Meng, Hao Li, Yilong Wang, Xingquan Zhao, 秦海强, Liping Liu et al. · 2022 · Journal of Neuroinflammation
84. Prognostic value of systemic immune‐inflammation index in CAD patients: Systematic review and meta‐analyses
    Zehao Zhao, Xiaoming Zhang, Tienan Sun, Xin Huang, Meishi Ma, Shiwei Yang, Yujie Zhou · 2023 · European Journal of Clinical Investigation
85. Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation
    Kim E. Dzobo, Arjen J. Cupido, Barend M. Mol, Lotte C.A. Stiekema, Miranda Versloot, Maaike Winkelmeijer, Jorge Peter, Anne-Marije Pennekamp, Stefan R. Havik, Frédéric Maxime Vaz et al. · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
86. 2024 Clinical practice guidelines for Acute myocardial infarction with ST segment elevation electrocardiogram
    Аверков Олег Валерьевич, GOHAR HARUTYUNYAN, Dmitry Viktorovich Duplyakov, Е. В. Константинова, N. N. Konstantinova, Roman M. Shakhnovich, I. S. Yavelov, Aleksey N. Yakovlev, Abugov Sa, Bagrat G. Alekyan et al. · 2025 · Russian Journal of Cardiology
87. Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation
    Ulrike Meyer-Lindemann, Carina Mauersberger, Anna-Christina Schmidt, Aldo Moggio, Julia Hinterdobler, Xinghai Li, David Khangholi, Jan Hettwer, Christian Gräßer, Alexander Dutsch et al. · 2022 · Frontiers in Immunology
88. Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
    Nicola Potere, Antonio Abbate, Yogendra M. Kanthi, Marc Carrier, Stefano A Toldo, Ettore Porreca, Marcello Di Nisio · 2023 · JACC Basic to Translational Science
89. Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases
    Qifeng Ou, Rachael Power, Matthew Dallas Griffin · 2023 · Frontiers in Immunology
90. Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice
    Cristina Madaudo, Giuseppe Coppola, Antonio Luca Maria Parlati, Egle Corrado · 2024 · International Journal of Molecular Sciences
91. A coalition to heal—the impact of the cardiac microenvironment
    Eldad Tzahor, Stefanie Dimmeler · 2022 · Science
92. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations
    P.M. Burger, Aruna D. Pradhan, Jannick A N Dorresteijn, Stefan Koudstaal, Martin Teraa, Gert Jan de Borst, Manon G. van der Meer, Arend Mosterd, Paul M. Ridker, Frank L.J. Visseren · 2023 · The American Journal of Cardiology
93. Interleukin-6 and Cardiovascular Events in Healthy Adults
    Muhammad Shahzeb Khan, Khawaja Muhammad Talha, Muhammad Haisum Maqsood, Jennifer A. Rymer, Barry A. Borlaug, Kieran F. Docherty, Ambarish Pandey, Florian Kahles, Maja Čikeš, Carolyn S.P. Lam et al. · 2024 · JACC Advances
94. Stability and reactivity study of bio-molecules brucine and colchicine towards electrophile and nucleophile attacks: Insight from DFT and MD simulations
    Yohannan Sheena Mary, Y. Shyma Mary, Stevan Armaković, Sanja J. Armaković, Rohitash Yadav, İsmail Çeli̇k, Pratap Mane, Brahmananda Chakraborty · 2021 · Journal of Molecular Liquids
95. Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs
    Kraler, Simon, Libby, Peter, Evans, Paul C., Akhmedov, Alexander, Schmiady, Martin O., Reinehr, Michael, Camici, Giovanni G., Lüscher, Thomas F. · 2021 · Arteriosclerosis, Thrombosis, and Vascular Biology
96. Anti‐inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy
    Yuyu Li, Yuxin Zhang, Jianrong Lu, Yong Yin, Jun Xie, Biao Xu · 2021 · Journal of Cellular and Molecular Medicine
97. Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy
    Max J. M. Silvis, Aernoud T.L. Fiolet, Tjerk S.J. Opstal, Mirthe Dekker, Daniel Suquilanda, Minka Živkovic, Michiel Duyvendak, Salem H.K. The, Leo Timmers, Willem A. Bax et al. · 2021 · Atherosclerosis
98. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
    Lixia Zhang, Chenchen Ai, Ming Bai, Jinglei Niu, Zheng Zhang · 2022 · International Journal of Molecular Sciences
99. Clonal hematopoiesis and atherosclerosis
    Ohad Oren, Aeron M Small, Peter Libby · 2024 · Journal of Clinical Investigation
100. Gout
     John D. FitzGerald · 2025 · Annals of Internal Medicine